Tania Mara Madalozzo | Author | SciTechnol

Tania Mara Madalozzo Author

tatianamara@concordia.ca +55(41) 3360-5000

Subjects of specialization
Cell Developmental Biology,Cell Cloning,Cell Regeneration,Diagnostics,Cell Motility

Affiliation
Cell Therapy and Biotechnology in Regenerative Medicine Department

Biography

Tania Mara Madalozzois currently working inCell Therapy and Biotechnology in Regenerative Medicine Department, The Pel� Pequeno Pr�ncipe Institute, Child and Adolescent Health Research, Pequeno Pr�ncipe Faculty, Curitiba, Paran�, Brazill. He has international experience on various programs, and also contributed and participated in different countries for diverse fields of study. Research interests reflect in wide range of publications in various national and international journals.

Publications

Review Article Subscription

General Requirement for Quality and Safety in Stem Cell and Cell-Based Products for Translational Therapy

Author(s):

Sandra Regina Barroso Ruiz Sella, Julio Cesar Francisco, Tania Mara Madalozzo, Ana Carolina Irioda, Bassam Felipe Morghabe, Reginaldo Justino Ferreira, Luiz Cesar Gu

Cells and tissues for transplantation constitute a specific class of health products with important therapeutic value, as they have in many cases no equivalent in restoring life-supporting or essential functions. There are many sources of regulations, rules, and guidance regarding the good tissue practices.Good manufacturing practice (GMP) quality, defined by both the European Medicines Agency and the Food andDrug Administration, is a requirement for clinical-grade cells, offering optimal defined quality and safety in cell transplantation.

DOI: 10.4172/2324-9293.1000108

Abstract HTML PDF